SonoChem

📍 Kenilworth, United Kingdom🗓 Founded 2019👥 4 employees💰 Last funded Apr 2021
SonoChem Limited has acquired, developed and patented (EU and USA), unique antibacterial and antiviral technologies relating to Anti Microbial Resistance (AMR) and Hospital Acquired Infections (HAI). The patents resulted from a major US$12 million European Union-funded seven nation programme ("SONO"), in coordination with Coventry University (UK). SonoChem refined a method for mass producing low cost antimicrobial textiles using Sonochemistry to produce nanoparticles, including copper and zinc, for infusion into textiles.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in SonoChem?
SonoChem has 1 investors on record on gritt.io, including 1 early-stage backers.
When did SonoChem last raise funding?
The most recent investment in SonoChem recorded on gritt.io was in April 2021.
When was SonoChem founded?
SonoChem was founded in 2019.
What industry is SonoChem in?
SonoChem operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is SonoChem based?
SonoChem is headquartered in Kenilworth, United Kingdom.